chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Body temperature, Diarrhoea, Ear infection, Headache
Clinical narrative: Ears infection; Diarrhea; Weakness; High temperature; Shingles; Severe headache.; This is a spontaneous report from a contactable consumer, the patient. A 65-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on 14Mar2021 (at the age of 65-year-old) as a single dose for COVID-19 immunisation. Medical history included penicillin allergy. Concomitant medications included atenolol (MANUFACTURER UNKNOWN) started on an unknown date for unknown indication. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN) via an unspecified route of administration in the left arm in Feb2021 (at the age 65-year-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, it was unknown whether the patient was tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 14Mar2021, the patient had ears infection, diarrhea, weakness, high temperature, and shingles all in a week. On an unknown date in Mar2021, (also reported as the past two weeks) the patient experienced a severe headache. The patient was in the emergency on 28Mar2021. The events resulted in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. The patient did not receive any treatment for the events. The clinical outcome of the event severe headache, ears infection, diarrhea, weakness, high temperature and shingles was not recovered at the time of this report.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Herpes zoster, Pyrexia
Clinical narrative: Ears infection; Diarrhea; Weakness; High temperature; Shingles; Severe headache.; This is a spontaneous report from a contactable consumer, the patient. A 65-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on 14Mar2021 (at the age of 65-year-old) as a single dose for COVID-19 immunisation. Medical history included penicillin allergy. Concomitant medications included atenolol (MANUFACTURER UNKNOWN) started on an unknown date for unknown indication. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN) via an unspecified route of administration in the left arm in Feb2021 (at the age 65-year-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, it was unknown whether the patient was tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 14Mar2021, the patient had ears infection, diarrhea, weakness, high temperature, and shingles all in a week. On an unknown date in Mar2021, (also reported as the past two weeks) the patient experienced a severe headache. The patient was in the emergency on 28Mar2021. The events resulted in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. The patient did not receive any treatment for the events. The clinical outcome of the event severe headache, ears infection, diarrhea, weakness, high temperature and shingles was not recovered at the time of this report.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 34.0
Sex: M
Vaccine: COVID19
Symptoms: Body temperature, Body temperature increased, Chills, Feeling cold, Pain
Clinical narrative: Intense chills/shivering; Feeling chilly and achy; Feeling chilly and achy; Temperature which was elevated; Mild fever; This is a spontaneous report from a contactable consumer, the patient. A 34-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL3247) via an unspecified route of administration in the left arm on 01Apr2021 at 13:15 (at the age of 34-year-old) as a single dose for COVID-19 immunisation. Medical history of the patient was reported as none. The patient had no known allergies. The patient's concomitant medications included levothyroxine (MANUFACTURER UNKNOWN) 125 mcg once daily and diphenhydramine (MANUFACTURER UNKNOWN) for an unknown indications started from an unknown dates. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL3247) via an unspecified route of administration in the left arm on 11Mar2021 at 13:15 as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 02Apr2021 in the morning at 03:00, the patient woke up feeling chilly and achy. The patient took his temperature which was elevated at 99.9 F. The patient spent the rest of the day with aches throughout his body and a mild fever. The highest the fever got to was 100.5 F. The patient thought, he was feeling better in the evening, but at 22:00 when the patient walked around he had intense chills/shivering. However, by the time he woke up on the next day 03Apr2021, the patient basically felt totally fine. The events did not result in doctor or other healthcare professional office/clinic visit/ emergency visit. Therapeutic measures were not taken as a result of adverse events. The clinical outcome of the events chilliness, aches, temperature elevation, fever and shivering was resolved on an unknown date in Apr2021.   No follow-up attempts are needed. No further information is expected.
Age: 34.0
Sex: M
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: Intense chills/shivering; Feeling chilly and achy; Feeling chilly and achy; Temperature which was elevated; Mild fever; This is a spontaneous report from a contactable consumer, the patient. A 34-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL3247) via an unspecified route of administration in the left arm on 01Apr2021 at 13:15 (at the age of 34-year-old) as a single dose for COVID-19 immunisation. Medical history of the patient was reported as none. The patient had no known allergies. The patient's concomitant medications included levothyroxine (MANUFACTURER UNKNOWN) 125 mcg once daily and diphenhydramine (MANUFACTURER UNKNOWN) for an unknown indications started from an unknown dates. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL3247) via an unspecified route of administration in the left arm on 11Mar2021 at 13:15 as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 02Apr2021 in the morning at 03:00, the patient woke up feeling chilly and achy. The patient took his temperature which was elevated at 99.9 F. The patient spent the rest of the day with aches throughout his body and a mild fever. The highest the fever got to was 100.5 F. The patient thought, he was feeling better in the evening, but at 22:00 when the patient walked around he had intense chills/shivering. However, by the time he woke up on the next day 03Apr2021, the patient basically felt totally fine. The events did not result in doctor or other healthcare professional office/clinic visit/ emergency visit. Therapeutic measures were not taken as a result of adverse events. The clinical outcome of the events chilliness, aches, temperature elevation, fever and shivering was resolved on an unknown date in Apr2021.   No follow-up attempts are needed. No further information is expected.
Age: 26.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Fatigue, Vaccination site pain
Clinical narrative: Joint pain; tiredness; injection site soreness; This is a spontaneous report from a non-contactable consumer, the patient. A 26-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 01Apr2021 at 14:30(at the age of 26-year-old) as a single dose for COVID-19 immunisation. No relevant medical history. The patient did not have any allergies to medications, food, or other products. Concomitant medications included etonogestrel (NEXPLANON) for unknown indication from unknown date. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 11Mar2021 at 16:00(at the age of 26-year-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 01Apr2021 at 18:30 the patient experienced tiredness ,injection site soreness(vaccination site pain) and Joint pain. The patient did not receive any treatment for the events. The events didn't result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events tiredness, injection site soreness(vaccination site pain) and joint pain were recovered.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Pain in extremity
Clinical narrative: Sore upper arm mild; Major fatigue; This is a spontaneous report from a contactable consumer, the patient. A 32-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the arm left on 02Apr2021 at 14:45 (at the age of 32-years-old) as a single dose for COVID-19 immunisation. Medical history included polycystic ovarian syndrome (PCOS), hypothyroidism, hypertension, hypertension intracranial, major depression and anxiety. The patient was allergic to pollen, soap and laundry detergent. Concomitant medications included acetazolamide (MANUFACTURER UNKNOWN), levothyroxine (MANUFACTURER UNKNOWN), drospirenone, ethinylestradiol betadex clathrate (YAZ), lisinopril (MANUFACTURER UNKNOWN) and potassium chloride (MANUFACTURER UNKNOWN). Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 04Apr2021, the patient experienced sore in upper arm, mild and major fatigue two days later after the vaccination. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. It was unknown whether the patient did receive any treatment for the events. The clinical outcome of the events sore upper arm, mild and major fatigue were resolving at the time of this report.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Back pain, Headache, Pain in extremity
Clinical narrative: Back pain; Headache; Arm pain; This is a spontaneous report from a contactable consumer, the patient. A 43-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 30Mar2021 at 13:15 (at the age of 43-years-old) as a single dose for COVID-19 immunisation. Medical history included allergy to avocado. Concomitant medication include apixaban (ELIQUIS). Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 30Mar2021, same day after vaccination, the patient experienced arm pain for two days. On 02Apr2021, days 3 and 4 after the shot, the patient experienced headache. On 04Apr2021, day 5 and 6 after the shot, the patient experienced back pain. The events arm pain, headache and back pain resulted in doctor or other healthcare professional office/clinic visit. The patient did not receive any treatment for the events. The clinical outcome of the event arm pain was resolved on 01Apr2021 while the events headache and back pain were not recovered.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 22.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Headache, Pain, Pain in extremity, Rash
Clinical narrative: Body Chills; Body aches; Rash; Headache; Sore arm; This is a spontaneous report from a contactable consumer, the patient. A 22-years-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8734) via an unspecified route of administration in the arm left on 03Apr2021 at 13:45 (at the age of 22-year-old) as a single dose for COVID-19 immunisation. Medical history included patient had known allergies to penicillin allergy and gluten. The patient had received unspecified concomitant medication within two weeks of vaccination. Prior to the vaccination, on an unknown date the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 03Apr2021 at 23:00, the patient experienced body chills, body aches, rash, headache and sore arm. No therapeutic measures were taken as a result of reported events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of body chills, body aches, rash, headache and sore arm was not resolved.  No follow-up attempts are needed. No further information is expected.
Age: 22.0
Sex: F
Vaccine: COVID19
Symptoms: SARS-CoV-2 test
Clinical narrative: Body Chills; Body aches; Rash; Headache; Sore arm; This is a spontaneous report from a contactable consumer, the patient. A 22-years-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8734) via an unspecified route of administration in the arm left on 03Apr2021 at 13:45 (at the age of 22-year-old) as a single dose for COVID-19 immunisation. Medical history included patient had known allergies to penicillin allergy and gluten. The patient had received unspecified concomitant medication within two weeks of vaccination. Prior to the vaccination, on an unknown date the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 03Apr2021 at 23:00, the patient experienced body chills, body aches, rash, headache and sore arm. No therapeutic measures were taken as a result of reported events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of body chills, body aches, rash, headache and sore arm was not resolved.  No follow-up attempts are needed. No further information is expected.
Age: 44.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Chills, Fatigue, Headache, Pain
Clinical narrative: Had a fever then with chills, fever was 100.3; Had a fever then with chills, fever was 100.3; Fatigue; Headache; sinus pressure; Severe chills; Aches; This is a spontaneous report received from a contactable consumer (patient). A 44-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP6955), via an unspecified route of administration in the arm left on 02Apr2021 (at the age of 44-year-old), as a single dose for COVID-19 immunisation. Medical history included chronic migraine and sulfa antibiotic allergy. Concomitant medications included galcanezumab gnlm (EMGALITY [GALCANEZUMAB GNLM]) taken for an unspecified indication, start and stop date were not reported; buspirone hydrochloride (BUSPAR) taken for an unspecified indication, start and stop date were not reported; sumatriptan (MANUFACTURER UNKNOWN), taken for an unspecified indication, start and stop date were not reported. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6203), via an unspecified route of administration in the left arm on 11Mar2021 at 09:00, as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient experienced severe chills on 02Apr2021, aches on 02Apr2021, fatigue on 02Apr2021, headache  and sinus pressure on 02Apr2021, had a fever then with chills, fever was 100.3 on 03Apr2021. Details were as follows: On 02Apr2021 (12 hours after the vaccination), the patient had severe chills and aches. It was stated that the chills were so severe it seemed body shut down. The chills and aches continued overnight into the next day (03Apr2021). On 03Apr2021, the patient had a fever then with chills, it was stated that the fever was 100.3 for most of the next day. On 02Apr2021, The aches and fatigue continued for the entire day after injection. On 02Apr2021, the patient also had a headache and what seemed like sinus pressure. It was stated that the chills were the worst. The patient did not receive any treatment for the events. The adverse events did not result in doctor or other healthcare professional office or clinic visit, and emergency room or department or urgent care. On 03Apr2021, the patient underwent body temperature and the result was 100.3 (unspecified units). The clinical outcome of severe chills, aches, had a fever then with chills, fever, fatigue, headache  and sinus pressure was unknown.   No follow-up attempts are needed. No further information is expected.
Age: 44.0
Sex: F
Vaccine: COVID19
Symptoms: Paranasal sinus discomfort, Pyrexia
Clinical narrative: Had a fever then with chills, fever was 100.3; Had a fever then with chills, fever was 100.3; Fatigue; Headache; sinus pressure; Severe chills; Aches; This is a spontaneous report received from a contactable consumer (patient). A 44-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP6955), via an unspecified route of administration in the arm left on 02Apr2021 (at the age of 44-year-old), as a single dose for COVID-19 immunisation. Medical history included chronic migraine and sulfa antibiotic allergy. Concomitant medications included galcanezumab gnlm (EMGALITY [GALCANEZUMAB GNLM]) taken for an unspecified indication, start and stop date were not reported; buspirone hydrochloride (BUSPAR) taken for an unspecified indication, start and stop date were not reported; sumatriptan (MANUFACTURER UNKNOWN), taken for an unspecified indication, start and stop date were not reported. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6203), via an unspecified route of administration in the left arm on 11Mar2021 at 09:00, as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient experienced severe chills on 02Apr2021, aches on 02Apr2021, fatigue on 02Apr2021, headache  and sinus pressure on 02Apr2021, had a fever then with chills, fever was 100.3 on 03Apr2021. Details were as follows: On 02Apr2021 (12 hours after the vaccination), the patient had severe chills and aches. It was stated that the chills were so severe it seemed body shut down. The chills and aches continued overnight into the next day (03Apr2021). On 03Apr2021, the patient had a fever then with chills, it was stated that the fever was 100.3 for most of the next day. On 02Apr2021, The aches and fatigue continued for the entire day after injection. On 02Apr2021, the patient also had a headache and what seemed like sinus pressure. It was stated that the chills were the worst. The patient did not receive any treatment for the events. The adverse events did not result in doctor or other healthcare professional office or clinic visit, and emergency room or department or urgent care. On 03Apr2021, the patient underwent body temperature and the result was 100.3 (unspecified units). The clinical outcome of severe chills, aches, had a fever then with chills, fever, fatigue, headache  and sinus pressure was unknown.   No follow-up attempts are needed. No further information is expected.
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Feeling abnormal, Inflammation, Lymphadenopathy
Clinical narrative: Seems weird; One swollen lymph node at the bottom of neck near collar bone.; its very inflamed; This is a spontaneous report from a contactable consumer, the patient. A 32-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: unknown) via an unspecified route of administration in the right arm on 29Mar2021 at 18:00 (at the age of 32-years-old) as a single dose for COVID-19 immunisation. Medical history included COVID-19. The patient had no known allergies to medications, food or other products. Concomitant medications included fluconazole (MANUFACTURER UNKNOWN) and multivitamin (BONDIBOOST); all from an unknown date for unknown indication. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 04Apr2021, the patient experienced one swollen lymph node at the bottom of her neck near collar bone and it seemed weird that it was just one and it was very inflamed. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. No therapeutic measures were taken as a result of the reported events. The clinical outcomes of swollen lymph node, weird and it was very inflamed were not recovered.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea, Fatigue, Nausea, Vomiting
Clinical narrative: nausea; Vomiting; fatigue; loose stools12 hours following the vaccine, hadloose stools; This is a spontaneous report from a contactable consumer, the patient. A 52-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE;Lot Number: ER8730) via an unspecified route of administration in the arm right on 27Mar2021 at 09:15 (at the age of 52-years-old) as a single dose for COVID-19 immunisation. Medical history included hypothyroidism and drug allergy ( allergic to sulfa drugs) . Concomitant medications included levothyroxine, liothyronine (NP THYROID). The patient previously took Chlorhexidine and experienced drug allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 27Mar2021, the patient experienced loose stools 12 hours following the vaccine and again had loose stools after 24 hours. On 28Mar2021 at 09:30, the patient experienced nausea, vomiting  and fatigue. The patient reported that, she had more diarrhea followed by extreme nausea and then vomiting and felt nausea all morning with extreme fatigue. Slept a great portion of the day and woke up the next morning feeling fine (48-hours later). The clinical outcome of the event loose stools 12 hours following the vaccine was resolved on an unknown date in 2021. The clinical outcome of the event nausea, vomiting and fatigue was resolved on 30Mar2021 at 09:30.  No follow-up attempts are needed. No further information is expected.,
Age: 60.0
Sex: M
Vaccine: COVID19
Symptoms: Oropharyngeal pain
Clinical narrative: Sore throat 3 days after shot; This is a spontaneous report from a contactable consumer, the patient. A 60-year-old male patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 01Apr2021 at 12:00 (at the age of 60-years-old) as a single dose for COVID-19 immunisation. Medical history included type II diabetes mellitus and hypertension. The patient was allergic to strawberries and penicillin. Concomitant medications included metformin (MANUFACTURER UNKNOWN), lisinopril (MANUFACTURER UNKNOWN), paracetamol (TYLENOL), atorvastatin (MANUFACTURER UNKNOWN) and chloramphenicol (CHLO); all for unknown indications from an unknown dates. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. It was unknown if the patient received any other vaccines within 4 weeks prior to the vaccination. On 04Apr2021 at 05:45, 3 days after the vaccination, the patient experienced sore throat. The patient did not receive any treatment for the reported adverse event. The event did not result in doctor or other healthcare professional office or clinic visit, and emergency room or department or urgent care. The clinical outcome of the event sore throat was not recovered at the time of this report.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Facial pain, Headache, Nausea, Pain in jaw, Sinus congestion
Clinical narrative: Headache; sinus congestion; face and jaw pain; face and jaw pain; nausea; vomiting; This is a spontaneous report from a non-contactable consumer, the patient. A 55-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0150) via an unspecified route of administration in the right arm on 02Apr2021 at 13:00 (at the age of 55-year-old), as a single dose for COVID-19 immunisation. Medical history included allergy to allium and lactose intolerance. Concomitant medications included cetirizine hydrochloride (ZYRTEC) from an unknown date for an unknown indication. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6208) via an unspecified route of administration in the right arm on 12Mar2021 at 13:30 (at the age of 55-year-old), as a single dose for COVID-19 immunisation. The patient did not receive any other vaccination within four weeks prior to the COVID-19 vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19.  On 03Apr2021 at 06:00, the patient experienced headache, sinus congestion, face pain, jaw pain, nausea and vomiting. The patient did not receive any treatment for these events. The events did not result in doctor or other healthcare professional office or clinic visit, and emergency room or department or urgent care. The clinical outcome of the events headache, sinus congestion, face pain, jaw pain, nausea and vomiting was recovered on an unknown date in Apr2021.  No follow-up attempts are needed. No further information is expected.
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Vomiting
Clinical narrative: Headache; sinus congestion; face and jaw pain; face and jaw pain; nausea; vomiting; This is a spontaneous report from a non-contactable consumer, the patient. A 55-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0150) via an unspecified route of administration in the right arm on 02Apr2021 at 13:00 (at the age of 55-year-old), as a single dose for COVID-19 immunisation. Medical history included allergy to allium and lactose intolerance. Concomitant medications included cetirizine hydrochloride (ZYRTEC) from an unknown date for an unknown indication. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6208) via an unspecified route of administration in the right arm on 12Mar2021 at 13:30 (at the age of 55-year-old), as a single dose for COVID-19 immunisation. The patient did not receive any other vaccination within four weeks prior to the COVID-19 vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19.  On 03Apr2021 at 06:00, the patient experienced headache, sinus congestion, face pain, jaw pain, nausea and vomiting. The patient did not receive any treatment for these events. The events did not result in doctor or other healthcare professional office or clinic visit, and emergency room or department or urgent care. The clinical outcome of the events headache, sinus congestion, face pain, jaw pain, nausea and vomiting was recovered on an unknown date in Apr2021.  No follow-up attempts are needed. No further information is expected.
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain upper, Chills, Decreased appetite, Dyspnoea, Headache
Clinical narrative: Shortness of breathe; Oxygen saturation at 96 since vaccine; Drops in blood pressure; Severe stomach pain; Loss of appetite; Intermittent fevers of 100-101 F; Chills; Severe body and muscular ache; Severe body and muscular ache; Persistent headache; This is a spontaneous report from a contactable consumer, the patient. A 32-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6205) via an unspecified route of administration in the arm left on 30Mar2021 at 10:00 (at the age of 32-year-old) as a single dose for COVID-19 immunisation. Medical history included congenital heart disease, PCOS, hemiplegic migraine, undiagnosed autoimmune disease (similar to Lupus/Hashimotos) and endometriosis. Concomitant medications included atomoxetine hydrochloride (STRATTERA), metoprolol (MANUFACTURER UNKNOWN), sertraline hydrochloride (ZOLOFT), probiotics (MANUFACTURER UNKNOWN) and fish oil (MANUFACTURER UNKNOWN); all from unknown date for unspecified indication. The patient previously took first dose of BNT162B2(PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6203) via an unspecified route of administration in the arm left on 10Mar2021(at the age of 32-year-old) as a single dose for COVID-19 immunisation and Iodine on unknown date for unspecified indication and experienced iodine allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 30Mar2021 at 11:00 the patient experienced Shortness of breathe and oxygen saturation at 96, drops in blood pressure, severe stomach pain, loss of appetite, intermittent fevers of 100-101 F, chills, severe body and muscular ache, persistent headache. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the reported event. The clinical outcome of the events shortness of breathe and oxygen saturation at 96, drops in blood pressure, severe stomach pain, loss of appetite, intermittent fevers of 100-101 F, chills, severe body and muscular ache, persistent headache were not resolved.   No follow-up attempts are needed. No further information is expected.
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Hypotension, Myalgia, Oxygen saturation, Oxygen saturation abnormal, Pain
Clinical narrative: Shortness of breathe; Oxygen saturation at 96 since vaccine; Drops in blood pressure; Severe stomach pain; Loss of appetite; Intermittent fevers of 100-101 F; Chills; Severe body and muscular ache; Severe body and muscular ache; Persistent headache; This is a spontaneous report from a contactable consumer, the patient. A 32-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6205) via an unspecified route of administration in the arm left on 30Mar2021 at 10:00 (at the age of 32-year-old) as a single dose for COVID-19 immunisation. Medical history included congenital heart disease, PCOS, hemiplegic migraine, undiagnosed autoimmune disease (similar to Lupus/Hashimotos) and endometriosis. Concomitant medications included atomoxetine hydrochloride (STRATTERA), metoprolol (MANUFACTURER UNKNOWN), sertraline hydrochloride (ZOLOFT), probiotics (MANUFACTURER UNKNOWN) and fish oil (MANUFACTURER UNKNOWN); all from unknown date for unspecified indication. The patient previously took first dose of BNT162B2(PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6203) via an unspecified route of administration in the arm left on 10Mar2021(at the age of 32-year-old) as a single dose for COVID-19 immunisation and Iodine on unknown date for unspecified indication and experienced iodine allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 30Mar2021 at 11:00 the patient experienced Shortness of breathe and oxygen saturation at 96, drops in blood pressure, severe stomach pain, loss of appetite, intermittent fevers of 100-101 F, chills, severe body and muscular ache, persistent headache. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the reported event. The clinical outcome of the events shortness of breathe and oxygen saturation at 96, drops in blood pressure, severe stomach pain, loss of appetite, intermittent fevers of 100-101 F, chills, severe body and muscular ache, persistent headache were not resolved.   No follow-up attempts are needed. No further information is expected.
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: Shortness of breathe; Oxygen saturation at 96 since vaccine; Drops in blood pressure; Severe stomach pain; Loss of appetite; Intermittent fevers of 100-101 F; Chills; Severe body and muscular ache; Severe body and muscular ache; Persistent headache; This is a spontaneous report from a contactable consumer, the patient. A 32-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6205) via an unspecified route of administration in the arm left on 30Mar2021 at 10:00 (at the age of 32-year-old) as a single dose for COVID-19 immunisation. Medical history included congenital heart disease, PCOS, hemiplegic migraine, undiagnosed autoimmune disease (similar to Lupus/Hashimotos) and endometriosis. Concomitant medications included atomoxetine hydrochloride (STRATTERA), metoprolol (MANUFACTURER UNKNOWN), sertraline hydrochloride (ZOLOFT), probiotics (MANUFACTURER UNKNOWN) and fish oil (MANUFACTURER UNKNOWN); all from unknown date for unspecified indication. The patient previously took first dose of BNT162B2(PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6203) via an unspecified route of administration in the arm left on 10Mar2021(at the age of 32-year-old) as a single dose for COVID-19 immunisation and Iodine on unknown date for unspecified indication and experienced iodine allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 30Mar2021 at 11:00 the patient experienced Shortness of breathe and oxygen saturation at 96, drops in blood pressure, severe stomach pain, loss of appetite, intermittent fevers of 100-101 F, chills, severe body and muscular ache, persistent headache. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the reported event. The clinical outcome of the events shortness of breathe and oxygen saturation at 96, drops in blood pressure, severe stomach pain, loss of appetite, intermittent fevers of 100-101 F, chills, severe body and muscular ache, persistent headache were not resolved.   No follow-up attempts are needed. No further information is expected.
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Lymph node pain, Lymphadenopathy
Clinical narrative: Painful lymph node in right armpit.; Swollen, painful lymph node in right armpit.; This is a spontaneous report from a contactable consumer, the patient. A 34-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 03Apr2021 at 10:15 (at the age of 34-years-old) as a single dose for COVID-19 immunisation. Medical history included endometriosis, adenomyosis, hypertension, ADHD (attention deficit hyperactivity disorder), allergies, asthma and penicillin allergy; all from unknown dates. Concomitant medications included norethisterone (NORETHINDRONE), lisinopril (MANUFACTURER UNKNOWN), bupropion hydrochloride (WELLBUTRIN) and lisdexamfetamine mesilate (VYVANSE); all from an unknown date for unknown indication and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 13Mar2021 at 10:00 (at the age of 34-years-old) as a single dose for COVID-19 immunisation and amoxicillin (MANUFACTURER UNKNOWN), chlorhexidine (MANUFACTURER UNKNOWN), labetalol (MANUFACTURER UNKNOWN) and clindamycin (MANUFACTURER UNKNOWN) and experienced drug allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 04Apr2021 at 18:00, the patient experienced swollen, painful lymph node in right armpit. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the events. The clinical outcome of the events swollen, painful lymph node in right armpit was not resolved at the time of this report.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 35.0
Sex: F
Vaccine: COVID19
Symptoms: Breast swelling, Breast tenderness, Lymph node pain, Lymphadenopathy
Clinical narrative: Left lymph nodes in left armpit and breast still swollen; Left lymph nodes tender; Breast swollen; Left lymph nodes in my left armpit andbreast are still swollen and tender.; This is a spontaneous report from a contactable other healthcare professional. A 35-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: UNKNOWN) via intramuscular route of administration in the left arm on 26Jan2021(at the age of 35-year-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Concomitant medications included levothyroxine sodium (SYNTHROID) and escitalopram oxalate(LEXAPRO), all from unknown dates and for unknown indications. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: UNKNOWN) via intramuscular route of administration in the left arm on 05Jan2021 as a single dose for COVID-19 immunisation. The patient previously took sulfamethoxazole, trimethoprim (BACTRIM) and experienced drug allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 27Jan2021, the patient experienced left lymph nodes in left armpit and breast swollen and tender. The patient reported that it was severe after the shot but never fully resolved. It felt like there was extra padding when her arm was resting against her side and tenderness. It was actually very irritating and she would like to know when this would resolve or if something needs to be done to return back to normal. The adverse  event resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as doctor(MD) observed swelling and no lumps. The clinical outcome of the event swollen left lymph nodes in left armpit, breast swollen, left lymph nodes tender and breast tenderness was not recovered at the time of this report.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Blood pressure increased, Headache, Pain, Paraesthesia
Clinical narrative: later that day blood pressure rose to 196/110/Again it Escalated the following day; body aches; headache; interment weakness; shaking in my arms; tingling sensation in my feet and lower legs; This is a spontaneous report from a contactable consumer (patient). A 58-year-old non-pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE), via an unspecified route of administration administered in right arm on 14Mar2021 16:00 (Batch/Lot Number: EP6955) (at the age of 58-year-old) as DOSE 1, SINGLE for covid-19 immunisation. The patient was not diagnosed with covid-19 prior to vaccination. Medical history included allergies to Nyquil and wasp. Concomitant medications included ademetionine (SAM-E); colecalciferol (D3); elderberry [sambucus nigra]; and magnesium carbonate (MAG 2 [MAGNESIUM CARBONATE]). On 15Mar2021 at 05:00 PM, the patient experienced later that day blood pressure rose to 196/110, body aches, headache, interment weakness, "shaking in my arms," and "tingling sensation in my feet and lower legs." It was further reported that the blood pressure rose to 196/110 and came down that night and again it escalated the following day and went to emergency room (ER) and was treated with blood pressure medication. The events resulted in emergency room/department or urgent care. The patient underwent lab tests and procedures which included blood pressure increased: 196/110 mmhg on 15Mar2021 and sars-cov-2 test (nasal swab): negative on 16Mar2021. Therapeutic measures were taken as a result of all events. The patient had not yet recovered from all events.  Follow-up attempts are completed. No further information is expected.
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: SARS-CoV-2 test, Tremor
Clinical narrative: later that day blood pressure rose to 196/110/Again it Escalated the following day; body aches; headache; interment weakness; shaking in my arms; tingling sensation in my feet and lower legs; This is a spontaneous report from a contactable consumer (patient). A 58-year-old non-pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE), via an unspecified route of administration administered in right arm on 14Mar2021 16:00 (Batch/Lot Number: EP6955) (at the age of 58-year-old) as DOSE 1, SINGLE for covid-19 immunisation. The patient was not diagnosed with covid-19 prior to vaccination. Medical history included allergies to Nyquil and wasp. Concomitant medications included ademetionine (SAM-E); colecalciferol (D3); elderberry [sambucus nigra]; and magnesium carbonate (MAG 2 [MAGNESIUM CARBONATE]). On 15Mar2021 at 05:00 PM, the patient experienced later that day blood pressure rose to 196/110, body aches, headache, interment weakness, "shaking in my arms," and "tingling sensation in my feet and lower legs." It was further reported that the blood pressure rose to 196/110 and came down that night and again it escalated the following day and went to emergency room (ER) and was treated with blood pressure medication. The events resulted in emergency room/department or urgent care. The patient underwent lab tests and procedures which included blood pressure increased: 196/110 mmhg on 15Mar2021 and sars-cov-2 test (nasal swab): negative on 16Mar2021. Therapeutic measures were taken as a result of all events. The patient had not yet recovered from all events.  Follow-up attempts are completed. No further information is expected.
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache, Pain in extremity
Clinical narrative: Headache; Fatigue; Sore arm; This is a spontaneous report from a contactable other healthcare professional, the Patient. A 33-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: En6204) via an unspecified route of administration in the right arm on an unknown date (at the age of 33-year-old), as a single dose for COVID-19 immunisation. Medical history included hashimotos thyroiditis and acid reflux. Concomitant medications included ethinylestradiol, norelgestromin (XULANE), sertraline (MANUFACTURER UNKNOWN) and multivitamin(MANUFACTURER UNKNOWN); all for unknown indication from an unknown date. The patient previously took cyclobenzaprine (MANUFACTURER UNKNOWN) and FLAGYL; both on unknown date for unspecified indication and experienced drug allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 31Mar2021, the patient experienced headache, fatigue and sore arm. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the events. The clinical outcome of the events headache, fatigue and sore arm was recovered on an unknown date.   No follow-up attempts are needed. No further information is expected.